George Papatheodoridis

34.4k total citations · 6 hit papers
393 papers, 17.0k citations indexed

About

George Papatheodoridis is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, George Papatheodoridis has authored 393 papers receiving a total of 17.0k indexed citations (citations by other indexed papers that have themselves been cited), including 300 papers in Epidemiology, 269 papers in Hepatology and 45 papers in Surgery. Recurrent topics in George Papatheodoridis's work include Liver Disease Diagnosis and Treatment (242 papers), Hepatitis C virus research (210 papers) and Hepatitis B Virus Studies (185 papers). George Papatheodoridis is often cited by papers focused on Liver Disease Diagnosis and Treatment (242 papers), Hepatitis C virus research (210 papers) and Hepatitis B Virus Studies (185 papers). George Papatheodoridis collaborates with scholars based in Greece, United States and United Kingdom. George Papatheodoridis's co-authors include Pietro Lampertico, Harry L.A. Janssen, Marı́a Buti, Thomas Berg, Kosh Agarwal, Fabien Zoulim, Frank Tacke, Εvangelos Cholongitas, Stephanos J. Hadziyannis and Athanasios J. Archimandritis and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

George Papatheodoridis

378 papers receiving 16.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

2017 3.7k citations Pietro Lampertico, George Papatheodoridis et al. profile →
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

2015 366 citations George Papatheodoridis, Pietro Lampertico et al. profile →
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

2017 271 citations George Papatheodoridis et al. profile →
Hepatitis B

2023 264 citations George Papatheodoridis et al. profile →
EASL Clinical Practice Guidelines on hepatitis delta virus

2023 112 citations Francesco Negro, Heiner Wedemeyer et al. profile →
Natural history of metabolic dysfunction-associated steatotic liver disease

2023 78 citations Vasileios Lekakis, George Papatheodoridis profile →

Peers

Countries citing papers authored by George Papatheodoridis

Since Specialization

Citations

This map shows the geographic impact of George Papatheodoridis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Papatheodoridis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Papatheodoridis more than expected).

Fields of papers citing papers by George Papatheodoridis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Papatheodoridis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Papatheodoridis. The network helps show where George Papatheodoridis may publish in the future.

Co-authorship network of co-authors of George Papatheodoridis

This figure shows the co-authorship network connecting the top 25 collaborators of George Papatheodoridis. A scholar is included among the top collaborators of George Papatheodoridis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Papatheodoridis. George Papatheodoridis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of Hormonal Status With Sarcopenia, Frailty and Outcome in Patients With Decompensated Cirrhosis 2025 ·Liver International ·(unknown), (unknown), (unknown), (unknown), Vasileios Lekakis, Lampros Chrysavgis, George Papatheodoridis, Anna Angelousi, Εvangelos Cholongitas	1
2	Sarcopenia As a Predictor of Survival and Complications of Patients With Cirrhosis After Liver Transplantation: A Systematic Review and Meta‐Analysis 2025 ·Clinical Transplantation ·Georgios Markakis, Jennifer C. Lai, (unknown), George Papatheodoridis, Θεοδώρα Ψαλτοπούλου, Manuela Merli, Theodoros Ν. Sergentanis, Εvangelos Cholongitas	6
3	Efficacy of Vaccination and Revaccination Against Hepatitis B Virus Using 2 Different Strategies in Patients With Inflammatory Bowel Disease 2024 ·Inflammatory Bowel Diseases ·(unknown), Konstantinos Κarmiris, (unknown), Evangelos Voudoukis, (unknown), (unknown), (unknown), Evanthia Zampeli, Eftychia Tsironi, Maria Tzouvala, George Papatheodoridis, (unknown)	2
4	Thyroid function, adipokines and mitokines in metabolic dysfunction‐associated steatohepatitis: A multi‐centre biopsy‐based observational study 2024 ·Liver International ·Matina Kouvari, Laura Valenzuela‐Vallejo, (unknown), Ornella Verrastro, George Papatheodoridis, Geltrude Mingrone, Jacob George, Christos S. Mantzoros	7
5	Growth Differentiation Factor 15 (GDF-15) Levels Associated with the Presence and Severity of NAFLD 2023 ·Metabolism ·Laura Valenzuela‐Vallejo, (unknown), (unknown), Chrysoula Boutari, (unknown), Margery A. Connelly, George Papatheodoridis, (unknown), Geltrude Mingrone, Christos S. Mantzoros	1
6	SARS-CoV-2 infection-related deregulation of blood lipids in a patient with -/-LDLR familial homozygous hypercholesterolemia: A case report 2023 ·Journal of clinical lipidology ·Dimitrios Bampatsias, (unknown), Dimitrios S. Karagiannakis, (unknown), Eleni Korompoki, (unknown), Erasmia Psimenou, Georgia Trakada, George Papatheodoridis, Κimon Stamatelopoulos	1
7	Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation 2023 ·Pathogens ·(unknown), Lampros Chrysavgis, (unknown), (unknown), Peter Lembessis, Εvangelos Cholongitas, Antonios Chatzigeorgiou, George Papatheodoridis	0
8	Left atrial strain and ventricular global longitudinal strain in cirrhotic patients using the new criteria of Cirrhotic Cardiomyopathy Consortium 2023 ·Liver International ·(unknown), Μaria Bonou, (unknown), (unknown), (unknown), (unknown), Efstathios Efstathopoulos, Constantina Aggeli, George Papatheodoridis, John Barbetseas, Εvangelos Cholongitas	10
9	Spleen stiffness can predict liver decompensation and survival in patients with cirrhosis 2022 ·Journal of Gastroenterology and Hepatology ·Dimitrios S. Karagiannakis, Theodoros Voulgaris, Georgios Markakis, (unknown), (unknown), Εvangelos Cholongitas, George Papatheodoridis	8
10	Epidemiology and treatment of hepatitis E in the liver transplantation setting: A literature review 2022 ·Journal of Viral Hepatitis ·Georgios Markakis, George Papatheodoridis, Εvangelos Cholongitas	7
11	Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts 2021 ·Liver International ·(unknown), George Papatheodoridis, Εvangelos Cholongitas	11
12	Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine 2020 ·Hepatology ·George Papatheodoridis, Theodoros Voulgaris, Μargarita Papatheodoridi, W. Ray Kim	19
13	Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond 2018 ·Scandinavian Journal of Gastroenterology ·Dimitrios S. Karagiannakis, Theodoros Voulgaris, Spyros I. Siakavellas, George Papatheodoridis, Jiannis Vlachogiannakos	26
14	The comprehensive outcomes of hepatitis C virus infection: A multi‐faceted chronic disease 2018 ·Journal of Viral Hepatitis ·Zobair M. Younossi, George Papatheodoridis, P. Cacoub, Francesco Negro, Heiner Wedemeyer, Linda Henry, Angelos Hatzakis	24
15	A baseline tool for predicting response to peginterferon alfa‐2a in HBeAg‐positive patients with chronic hepatitis B 2018 ·Alimentary Pharmacology & Therapeutics ·Henry Lik‐Yuen Chan, Diethelm Messinger, George Papatheodoridis, Markus Cornberg, Qing Xie, Teerha Piratvisuth, Hong Ren, Patrick Kennedy, A. Thompson, (unknown), Georgios Bakalos, Vedran Pavlovic, Pietro Lampertico	22
16	Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease 2016 ·Canadian Journal of Gastroenterology and Hepatology ·Giorgos Bamias, (unknown), Ioanna Delladetsima, (unknown), Spyros I. Siakavellas, Ioannis Koutsounas, (unknown), Jiannis Vlachogiannakos, (unknown), George L. Daikos, George Papatheodoridis, Spiros D. Ladas	6
17	Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection 2016 ·Digestive and Liver Disease ·Rosa Lombardi, Helen Sambatakou, (unknown), (unknown), George Papatheodoridis, Emmanuel Tsochatzis	44
18	On‐treatment prediction of sustained response to peginterferon alfa‐2a for HB eAg‐negative chronic hepatitis B patients 2014 ·Liver International ·Ioannis Goulis, Stylianos Karatapanis, Evangelos Akriviadis, Melanie Deutsch, George Ν. Dalekos, M. Raptopoulou‐Gigi, Konstantinos Mimidis, G. Germanidis, (unknown), Christos Triantos, Ηλίας Ζιντζαράς, Georgios Bakalos, George Papatheodoridis	23
19	Mycophenolate mofetil: An alternative maintenance immunosuppressant in liver transplantation, which improves renal dysfunction. 1998 ·UCL Discovery (University College London) ·George Papatheodoridis, James O’Beirne, Pramod K. Mistry, (unknown), Keith Rolles, AK Burroughs	2
20	Predictive factors of histological outcome in posttransplant HCV infection. 1998 ·UCL Discovery (University College London) ·George Papatheodoridis, (unknown), (unknown), (unknown), (unknown), Geoffrey Dusheiko, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact